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Abstract
Background—There are insufficient data to make firm dietary recommendations for patients
with inflammatory bowel disease (IBD). Yet patients frequently report that specific food items
influence their symptoms. In this study, we describe patients’ perceptions about the benefits and
harms of selected foods and patients’ dietary patterns.
Methods—CCFA Partners is an ongoing internet-based cohort study of patients with IBD. We
used a semi-quantitative food frequency questionnaire to measure dietary consumption patterns
and open-ended questions to elicit responses from patients about food items they believe
ameliorate or exacerbate IBD. We categorized patients into four mutually exclusive disease
categories: CD without an ostomy or pouch (CD), UC without an ostomy or pouch (UC), CD with
an ostomy (CD-ostomy), and UC with a pouch (UC-pouch).
Results—Yogurt, rice, and bananas were more frequently reported to improve symptoms
whereas non-leafy vegetables, spicy foods, fruit, nuts, leafy vegetables, fried foods, milk, red
meat, soda, popcorn, dairy, alcohol, high-fiber foods, corn, fatty foods, seeds, coffee, and beans
were more frequently reported to worsen symptoms. Compared to CD patients, CD-ostomy
patients reported significantly greater consumption of cheese (odds ratio (OR) 1.56, 95% CI 1.03–
2.36), sweetened beverages (OR 2.14, 95% CI 1.02–1.03), milk (OR 1.84, 95% CI 1.35–2.52),
pizza (OR 1.57, 95% CI 1.12–2.20), and processed meats (OR 1.40; 95% CI 1.04–1.89).
Conclusions—Patients identified foods that they believe worsen symptoms and restricted their
diet. Patients with ostomies ate a more liberal diet. Prospective studies are needed to determine
whether diet influences disease course.
Introduction
Crohn’s disease and ulcerative colitis can lead to poor quality of life, weight loss, and
malnutrition.1–5 Prior studies have explored the role of diet in the etiology of inflammatory
bowel disease (IBD) and demonstrated the benefit of enteral nutrition in mucosal healing.6–9
However, there are insufficient data regarding the role of diet in the management of IBD to
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make firm recommendations on dietary modifications. Consequently, numerous
unsubstantiated recommendations exist on dietary modifications for patients with IBD.10–13
Likewise, there is a paucity of research in the literature describing the dietary patterns of
patients with Crohn’s disease and ulcerative colitis, whether these patterns differ between
disease types, and whether the presence of an ostomy or pouch influences dietary intake and
symptoms associated with consuming certain food items.
One approach to identifying dietary patterns that may influence the course of the disease is
to query patients. However, within a single center, it is difficult to accumulate sufficiently
large numbers of patients with different phenotypes to draw strong conclusions from these
patient reports. CCFA Partners is an internet-based cohort study that includes a very large
number of patients with IBD. By querying patients within the CCFA Partners study, we
describe IBD patients’ perceptions of the benefits and harms of selected foods and their
dietary patterns according to disease type, disease activity, and self-reported perception of
foods that ameliorate or worsen IBD.
Methods
CCFA Partners is an ongoing internet-based cohort study of patients with IBD.14 Invitations
to join the cohort were sent via email to individuals listed on rosters of the Crohn’s and
Colitis Foundation of America (CCFA). Respondents completed a baseline survey that
included modules on disease characteristics, medications, and dietary patterns. This study
used data available from June 17, 2011 through October 4, 2011. Patients with implausible
age of diagnosis were excluded (3 subjects).
Disease type was recorded within CCFA Partners based on patient self-reports. For the
purpose of this study, we categorized patients into four mutually exclusive disease subtypes:
CD without an ostomy or pouch (referred to as CD), UC without an ostomy or pouch
(referred to as UC), CD with an ostomy (CD-ostomy), and UC with a pouch (UC-pouch).
Any patient with an ostomy was excluded from the UC-pouch group.
We used the semi-quantitative food frequency questionnaire developed by the National
Cancer Institute to quantify average daily consumption in the prior month of red meat, fruit,
leafy vegetables, other vegetables, cheese, sweetened beverages, milk, tomatoes, dessert
items, potatoes, soda, beans, pizza, processed meats, ice cream, and popcorn (http://
riskfactor.cancer.gov/studies/nhanes/dietscreen/).
The baseline CCFA Partners survey included open-ended questions to elicit responses
regarding food items that patients believed exacerbated or ameliorated their symptoms. For
the first 2,000 respondents and all patients who reported having an ostomy or pouch, the free
text responses were manually reviewed and grouped into categories including similar food
items (i.e., steak and pork were grouped into red meat). We only report results if at least 5%
of participants within a disease subtype identified a food item as ameliorating or worsening
symptoms.
Descriptive data are reported in percentages, mean, median, and interquartile range (IQR).
To analyze whether food items were more commonly reported to improve or worsen
symptoms, we used the sign test with the Bonferroni method to adjust for multiple
comparisons (p<0.00039 was required to be considered statistically significant). The
Wilcoxon rank-sum or chi squared test was used to evaluate whether patients adhered to
their stated dietary patterns by consuming more of the foods that improved symptoms and
less of the foods that worsened symptoms. These analyses were performed on the 2,329
patients whose free text responses were manually reviewed.
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The remaining statistical analyses were performed on the entire cohort of 6,768 patients.
Patients were grouped into two categories of disease activity based on self-reported survey
answers. Self-reported disease activity was assessed with a 5-point Likert scale with
categories of remission, minimal, mild, moderate, and severe symptoms. Patients with
inactive disease were those who reported being in remission or having minimal symptoms.
Patients with active disease activity were those who reported having mild, moderate, or
severe symptoms. Reported food consumption for each group based on the food frequency
questionnaire was categorized into quartiles from least to most consumption. Logistic
regression analysis adjusting for age, sex, and previous surgery was performed to determine
whether disease activity was associated with the level of consumption of specific food items.
Logistic regression adjusted for age, sex, and self-reported disease activity was used to
compare food item consumption across IBD subtypes. We planned a priori to compare the
highest quartile to the lowest quartile in the logistic regression models.
Results
The final cohort included 6,768 patients; analysis of free text responses to foods that
exacerbate and ameliorate symptoms was performed on 2,329 respondents (1,121 CD, 597
UC, 206 UC-pouch, and 405 CD-ostomy) (Table 1). Across each of the IBD subtypes,
approximately 70% of respondents were women, the median age was 42–49 and 58–73% of
respondents reported having minimal disease activity. The patient demographics of the
larger source cohort has been previously described.14
The most frequently reported foods that ameliorated and exacerbated symptoms are
displayed in Table 2. Yogurt and rice were more frequently reported to improve symptoms
within all subgroups of patients while bananas were more commonly reported to improve
symptoms in the UC-pouch group. Non-leafy vegetables, spicy foods, fruit, nuts, leafy
vegetables, fried foods, milk, red meat, soda, popcorn, dairy, alcohol, high-fiber foods, corn,
fatty foods, seeds, coffee, and beans were more frequently reported to worsen symptoms
within most disease categories.
Further analysis showed that patients ate less red meat, dairy, soda, sugar, high-fiber foods,
gluten, milk, fruit, leafy vegetables, beans, non-leafy vegetables, tomatoes, pizza, cheese,
chocolate, and ice cream when they reported that these items worsened their symptoms
(p<0.05 for all comparisons, data included in supplemental Table 1). Conversely, patients
ate more vegetarian diet, organic foods, cereal, milk, fruit juice, fruit, leafy vegetables,
potatoes, whole grains, non-leafy vegetables, cheese, and ice cream when they reported that
these items improved symptoms (p<0.05 for all comparisons, data included in supplemental
Table 2).
The entire patient cohort of 4,001 patients with CD, 2,156 with UC, 206 with UC-pouch,
and 405 with CD-ostomy was analyzed to compare consumption rates within disease
categories (Table 3). As compared to patients with CD, those with UC reported significantly
greater consumption of fruit (OR 1.82, 95% CI 1.49–2.22), leafy vegetables (OR 1.87, 95%
CI 1.59–2.20), non-leafy vegetables (OR 1.49, 95% CI 1.27–1.74), tomatoes (OR 1.16, 95%
CI 1.02–1.33), beans (OR 1.51, 95% CI 1.30–1.75), and popcorn (OR 1.28, 95% CI 1.10–
1.48), and significantly less consumption of sweetened beverages (OR 0.82, 95% CI 0.71–
0.96), potatoes (OR 0.83, 95% CI 0.72–0.96), soda (OR 0.61, 95% CI 0.52–0.70), and
processed meats (OR 0.85, 95% CI 0.73–0.99). Compared to CD patients without an
ostomy, CD patients with an ostomy reported significantly greater consumption of cheese
(OR 1.56, 95% CI 1.03–2.36), sweetened beverages (OR 2.14, 95% CI 1.02–1.03), milk
(OR 1.84, 95% CI 1.35–2.52), pizza (OR 1.57, 95% CI 1.12–2.20), and processed meats
(OR 1.40, 95% CI 1.04–1.89), and significantly less consumption of beans (OR 0.72, 95%
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CI 0.52–0.99). Compared to UC patients without a pouch, UC patients with a pouch
reported significantly greater consumption of sweetened beverages (1.68, 95% CI 1.17–
2.43) and significantly less consumption of leafy vegetables (OR 0.58, 95% CI 0.38–0.89).
Table 4 shows the odds ratios for self-reported food consumption based on self-reported
disease activity. CD patients with active disease reported consuming significantly less fruit
(OR 0.43, 95% CI 0.33–0.57), leafy vegetables (OR 0.44, 95% CI 0.36–0.54), non-leafy
vegetables (OR 0.54, 95% CI 0.44–0.65), milk (OR 0.78, 95% CI 0.62–0.97), tomatoes (OR
0.73, 95% CI 0.62–0.86), dessert (OR 0.71, 95% CI 0.61–0.83), beans (OR 0.59, 95% CI
0.48–0.71), pizza (OR 0.77, 95% CI 0.62–0.96), processed meats (OR 0.78, 95% CI 0.65–
0.93), ice cream (OR 0.71, 95% CI 0.59–0.86), and popcorn (OR 0.74, 95% CI 0.61–0.89)
than those without active disease. CD patients with active disease reported consuming more
sweetened beverages (OR 1.29, 95% CI 1.09–1.53) and soda (OR 1.51, 95% CI 1.29–1.78)
than those without active disease.
UC patients with active disease reported consuming significantly less fruit (OR 0.39, 95%
CI 0.27–0.55), leafy vegetables (OR 0.40, 95% CI 0.30–0.53), non-leafy vegetables (OR
0.59, 95% CI 0.45–0.77), tomatoes (OR 0.67, 95% CI 0.54–0.84), beans (OR 0.49, 95% CI
0.38–0.64), and ice cream (OR 0.66, 95% CI 0.50–0.86) than those without active disease.
UC patients with active disease reported consuming more soda (OR 1.32, 95% CI 1.03–
1.71) than those without active disease.
CD-ostomy patients with active disease reported consuming significantly less fruit (OR
0.19, 95% CI 0.05–0.64), leafy vegetables (OR 0.34, 95% CI 0.15–0.75), non-leafy
vegetables (OR 0.32, 95% CI 0.15–0.68), and beans (OR 0.43, 95% CI 0.20–0.94) than
those without active disease. UC-pouch patients with active disease reported significantly
less consumption of red meat (OR 0.11, 95% CI 0.02–0.54) and fruit (OR 0.14, 95% CI
0.03–0.71) than those without active disease.
Discussion
This study comprehensively assessed dietary patterns and beliefs among a large cohort of
patients with IBD. We identified numerous food groups that patients more frequently
identified as worsening symptoms and a few food items that were more commonly reported
to improve symptoms. While dietary patterns differed by disease type, the self-reported
perception of what worsened or improved symptoms was relatively consistent across disease
types. We also documented that patients’ dietary patterns are linked to their perceptions of
how food items influence their disease course. Not surprisingly, patients with active disease
reported different dietary patterns than those whose disease was quiescent. Finally, those
who had undergone surgery to create an ostomy reported more liberalized dietary patterns.
Patients were far more likely to describe foods that worsened symptoms than improved
them. While several food items were not ranked because fewer than 5% of patients reported
the food as helping or hurting, many of these items were still more frequently reported to
worsen symptoms and a few to improve symptoms. The list of foods that patients believed
worsened symptoms was broad but with some evidence of a pattern. Dairy was reported to
worsen symptoms by multiple groups, which could reflect a component of lactose
intolerance. Many of the food groups commonly reported to worsen symptoms were also
higher in fiber (e.g., vegetables, fruits, and corn).
Past research has shown that red meat is associated with early relapse of disease in patients
with UC.15 This hypothesis was further supported in our study as red meat was more
commonly reported to worsen symptoms in all disease categories except UC-pouch. When
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we compared UC to CD, self-reported consumption of red meat was not significantly less in
the UC group, suggesting that red meat might influence the course of CD as well.
The fruit and vegetable groups included diverse items, and it is therefore difficult to
generalize the impact of these food groups on patients’ symptoms. For example, bananas
were more commonly reported to improve symptoms while tomatoes were more commonly
reported to exacerbate symptoms.
These data provide a summary of the anecdotal perceptions of a broad cohort of patients.
However, we are not able to assess whether these food items actually impact bowel
inflammation or merely patients’ symptoms. Food items such as milk, dairy, and high fiber,
all foods that are associated with intolerances, may not exacerbate the disease process but
simply lead to symptoms as they would in individuals without IBD.16–20 The consistent
pattern of foods commonly reported to worsen symptoms across the disease groups supports
this hypothesis. Ultimately, as with medications, controlled trials of dietary interventions are
needed to test the hypotheses that these food items influence disease course.
Although we were unable to determine what experiences led patients to believe that certain
foods worsen their symptoms, our data confirmed that patients with IBD restrict their dietary
pattern due to active symptoms or fear of exacerbating symptoms. We observed decreased
consumption of selected food items among patients with active symptoms and among those
who believed that certain food items worsen their symptoms. Furthermore, definitive
surgery for Crohn’s disease was associated with different dietary patterns. After adjusting
for self-reported disease activity, CD-ostomy patients consumed more cheese, sweetened
beverages, milk, pizza, and processed meats than those without ostomies. These data suggest
that one of the benefits of surgical approaches to managing IBD may be the ability to
liberalize one’s diet. Alternatively, patients who have a more inclusive diet may be more
willing to undergo ostomy surgery.
Zallot et al. recently assessed the dietary patterns and beliefs of 244 patients with IBD,
among whom 25–80% of patients believed eating spicy foods, vegetables, fruit, soda, fiber,
dairy, and/or coffee could lead to relapse.21 These items were all more frequently reported
as worsening symptoms in our study. The observation by Zallot et al. that UC patients seem
to tolerate raw vegetables better than CD patients was also consistent with our observation
that UC patients ate significantly more non-leafy and leafy vegetables than CD patients.
In Zallot’s study, approximately 25% of patients stated dairy exacerbated their symptoms,
yet only 4% adopted a dairy-free diet.21 In contrast, our study population reported eating
more of foods that made them better and less of foods that made them worse (including
dairy). This suggests that while patients may not necessarily adopt a full elimination diet,
they do appear to limit their intake of food items that exacerbate symptoms. Whether there is
a clinical advantage to complete elimination of certain foods requires further testing in
controlled studies.
Self-imposed dietary restrictions may have an important impact on nutritional status. For
example, 40–78% of IBD patients are believed to have inadequate folate intake.22,23 Folate
is found predominately in leafy and non-leafy vegetables such as spinach, asparagus, and
Brussels sprouts.1 Patients avoiding these foods for fear of worsening symptoms may be
vulnerable to inadequacies in their diet. Additionally, 80–86% of IBD patients are reported
to have inadequate dietary intake of calcium, possibly as a result of avoiding milk and dairy,
which were also identified as foods thought to worsen symptoms.17,18
This study relied on patients’ self-reported answers to survey questions to characterize
disease type, dietary patterns, and symptoms. Some patients were unaware of disease
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location, and the reliability of self-reported disease distribution and history of fistula or
strictures is unknown. Therefore, we did not attempt to subcategorize patients on these
phenotypic characteristics. However, one would anticipate that self-reported disease type
(i.e., CD versus UC) and the presence of an ostomy or pouch should be reliable. Food
frequency questionnaires are not a perfect method to quantify dietary intake but are useful to
discriminate between those with high and low levels of intake.24 Because we categorized
participants into quartiles and based our conclusions on comparisons of those in the highest
and lowest quartiles, there should be relatively little misclassification. We assessed dietary
intake over the prior month but disease activity at a single point in time. We cannot state
with certainty that those who reported active disease had such symptoms over the course of
the prior month, and some of the patients who reported no or minimal symptoms may have
had active disease during the prior month. Such misclassification would have been expected
to bias us toward the null. Thus, our reported associations between disease activity and
dietary patterns may be an underestimate of the magnitude of the association.
CCFA Partners is a convenience sample of patients with IBD. It is possible that this cohort
differs from other populations of patients with IBD such as having particularly strong beliefs
about diet and IBD. The similar results of this study and that of Zallot et al.21 argue against
such.
There are several important strengths of this study. To our knowledge, this is the largest
study of IBD and diet to date. The volunteers were sufficiently interested in IBD to complete
an online survey and may be more aware of their disease and symptoms than less motivated
subjects. The food frequency questionnaire was meticulously developed by the National
Cancer Institute and has been used in large national studies. We also had access to free text
responses, thereby not limiting our food data to preselected food items. By linking free text
responses with the food frequency questionnaire, we were able to confirm that participants
actually followed the dietary patterns that they believed would improve their disease course.
Patients often ask about the role of diet in controlling their IBD symptoms, and physicians
struggle to make evidence-based recommendations. At present there is insufficient
information to make strong recommendations about diet. We have identified food items that
patients commonly believe to worsen, and in a few cases, help their IBD. Planned
prospective follow-up of this cohort could demonstrate whether these dietary elements are
associated with disease flares or remission and provide more support for the role of diet and
IBD activity. We also observed that CD-O patients had a more liberalized diet. This may be
an important consideration for patients contemplating surgery with ostomy formation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Patient Demographics
CD UC CD-O UC-P
Total Patients 1121 597 405 206
Female (%) 72.4% 64.2% 71.6% 69.4%
Age
 Mean 43.9 44.9 48.2 41.6
 Median 44 44 49 42
 IQR 24 23 21 22
Self-Reported Disease Activity
 Remission 24.1% 36.0% 39.8% 41.8%
 Minimal symptoms 33.4% 32.2% 32.8% 30.6%
 Mild symptoms 21.0% 15.9% 13.1% 15.1%
 Moderate symptoms 14.4% 10.2% 10.1% 8.3%
 Severe symptoms 5.1% 5.0% 3.7% 2.4%
Disease Location (CD)*
 UGI 32.0% N/A 39.0% N/A
 Jejunum 21.6% N/A 31.6% N/A
 Ileum 65.0% N/A 68.9% N/A
 Colon 58.0% N/A 88.2% N/A
 Rectum 35.3% N/A 78.5% N/A
Stricture 52.7% N/A 75.3% N/A
Fistula now 7.1% N/A 13.8% N/A
Fistula ever 39.7% N/A 80.5% N/A
Disease location (UC)
 Rectum N/A 5.0% N/A 1.0%
 Rectum/Sigmoid N/A 12.2% N/A 1.5%
 Left-sided N/A 28.0% N/A 9.7%
 Extensive colitis N/A 7.9% N/A 4.9%
 Pancolitis N/A 29.7% N/A 75.7%
 Uncertain N/A 16.6% N/A 6.8%
CD-Crohn’s disease, UC-ulcerative colitis, O-Ostomy, P-Pouch. CD patients with both an ostomy and pouch were included in the CD-O group.
*
Disease location categories are not mutually exclusive. If the participant answered uncertain they were assumed not to have involvement of the
bowel segment. 13 participants (1.2%) answered uncertain for all bowel locations, all within the CD no O/P group.
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Table 2
Frequency of patient-reported foods that improve or worsen symptoms.









 Yogurt 108, 7* 54, 3* 26, 0* 19, 0*
 Rice 59, 3* 30, 3* 20, 3† 16, 0*
 Bananas NR NR NR 14, 0*
Worsened Symptoms
 Non-Leafy Vegetables 28, 221* 29, 81* 7, 90* 3, 36*
 Spicy Foods 1, 145* 3, 79* 0, 46* 0, 33*
 Fruit 50, 136* 40, 63 22, 51† 15, 24
 Nuts 3, 120* 1, 33* 0, 52* 0, 21*
 Leafy Vegetables 6, 115* 2, 50* 2, 29* 1, 14†
 Fried Foods 0, 105* 0, 53* 0, 22* 0, 11†
 Milk 6, 105* 0, 49* 5, 28* 2, 14†
 Red Meat 6, 103* 7, 47* 2, 24* NR
 Soda 11, 99* 0, 46* 0, 33* 0, 28*
 Popcorn 2, 97* NR 0, 27* 0, 18*
 Dairy 3, 94* 1, 56* NR 0, 12†
 Alcohol 0, 90* 0, 54* NR 0, 23*
 High Fiber 19, 87* 19, 35† 7, 46* NR
 Corn 0, 77* 0, 31* 0, 29* NR
 Fatty Foods 0, 62* NR NR NR
 Seeds NR NR 0, 22* NR
 Coffee NR 4, 37* NR NR
 Beans NR 5, 30* NR NR
A response rate of 5% for either improvement or worsening of symptoms in at least one of the study groups was required for the food item to be
included in the above table. Where the response was less than 5%, results are not reported (NR). There were 106 additional food items reported by
less than 5% of each group. B-Number of patients who stated food item made them better. W-Number of patients who stated food item made them
worse. P values were from the sign test. Using the Bonferroni method to correct for multiple comparisons, statistical significance is defined as
p<0.00039 (i.e., 0.05/127). Those items meeting this threshold are identified with an asterisk (*). Items with a P value between 0.05 and 0.00039
are identified with †.
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Table 3
Odds Ratios for food consumption between IBD subtypes.






Red Meat 0.87 (0.74–1.01) 1.20 (0.90–1.61) 1.13 (0.46–1.13)
Fruit 1.82 (1.49–2.22) 0.67 (0.45–1.00) 0.62 (0.36–1.09)
Leafy Vegetables 1.87 (1.59–2.20) 0.72 (0.51–1.01) 0.58 (0.38–0.89)
Non-Leafy Vegetables 1.49 (1.27–1.74) 0.76 (0.56–1.03) 0.77 (0.51–1.18)
Cheese 0.95 (0.75–1.20) 1.56 (1.03–2.36) 1.54 (0.84–2.80)
Sweetened Beverages 0.82 (0.71–0.96) 2.14 (1.02–1.03) 1.68 (1.17–2.43)
Milk 0.83 (0.69–1.01) 1.84 (1.35–2.52) 1.11 (0.67–1.82)
Tomato 1.16 (1.02–1.33) 1.05 (0.81–1.37) 1.07 (0.74–1.54)
Dessert 0.90 (0.79–1.02) 0.85 (0.66–1.09) 1.37 (0.99–1.89)
Potato 0.83 (0.72–0.96) 1.27 (0.98–1.65) 1.25 (0.84–1.86)
Soda 0.61 (0.52–0.70) 1.19 (0.91–1.54) 0.84 (0.55–1.29)
Beans 1.51 (1.30–1.75) 0.72 (0.52–0.99) 0.82 (0.55–1.23)
Pizza 0.92 (0.77–1.11) 1.57 (1.12–2.20) 1.00 (0.59–1.70)
Processed Meats 0.85 (0.73–0.99) 1.40 (1.04–1.89) 0.93 (0.61–1.41)
Ice Cream 0.94 (0.80–1.10) 1.09 (0.81–1.45) 1.17 (0.74–1.83)
Popcorn 1.28 (1.10–1.48) 0.82 (0.60–1.12) 0.89 (0.59–1.33)
Odds ratios (OR) are presented for the highest quartile vs. the lowest quartile of consumption of food items among those with UC relative to CD,
CD-O relative to CD, and UC-P relative to UC. Bolded items are statistically significant. Odds ratios are adjusted for age, sex, and disease activity.
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Red Meat 0.95 (0.79–1.14) 0.88 (0.68–1.14) 1.21(0.62–2.33) 0.11 (0.02–0.54)
Fruit 0.43 (0.33–0.57) 0.39 (0.27–0.55) 0.19 (0.05–0.64) 0.14 (0.03–0.71)
Leafy Vegetables 0.44 (0.36–0.54) 0.40 (0.30–0.53) 0.34 (0.15–0.75) 0.56 (0.22–1.44)
Non-Leafy Vegetables 0.54 (0.44–0.65) 0.59 (0.45–0.77) 0.32 (0.15–0.68) 0.86 (0.36–2.08)
Cheese 0.77 (0.58–1.01) 1.05 (0.70–1.56) 0.56 (0.22–1.42) 0.60 (0.14–2.54)
Sweetened Beverages 1.29 (1.09–1.53) 1.29 (0.99–1.66) 0.65 (0.38–1.12) 0.68 (0.29–1.61)
Milk 0.78 (0.62–0.97) 0.89 (0.64–1.22) 0.82 (0.42–1.57) 0.40 (0.12–1.35)
Tomato 0.73 (0.62–0.86) 0.67 (0.54–0.84) 0.58 (0.32–1.06) 0.83 (0.37–1.86)
Dessert 0.71 (0.61–0.83) 1.87 (0.70–1.08) 0.78 (0.45–1.36) 0.67 (0.32–1.39)
Potato 0.92 (0.77–0.09) 1.03 (0.81–1.32) 0.57 (0.32–1.01) 0.84 (0.33–2.11)
Soda 1.51 (1.29–1.78) 1.32 (1.03–1.71) 1.19 (0.69–2.07) 1.48 (0.59–3.72)
Beans 0.59 (0.48–0.71) 0.49 (0.38–0.64) 0.43 (0.20–0.94) 0.40 (0.16–1.04)
Pizza 0.77 (0.62–0.96) 0.94 (0.69–1.30) 0.97 (0.49–1.92) 0.33 (0.09–1.27)
Processed Meats 0.78 (0.65–0.93) 0.97 (0.75–1.25) 1.21 (0.63–2.32) 0.64 (0.26–1.57)
Ice Cream 0.71 (0.59–0.86) 0.66 (0.50–0.86) 0.84 (0.46–1.54) 0.72 (0.26–1.97)
Popcorn 0.74 (0.61–0.89) 0.79 (0.61–1.02) 0.58 (0.28–1.18) 0.72 (0.29–1.76)
Odds ratios (OR) are presented for the highest quartile vs. the lowest quartile of consumption of food items among those with active disease
relative to inactive disease. Bolded items are statistically significant. Odds ratios are adjusted for age, sex, and prior surgery.
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